EuroGRAFT
Members Area COST Action number CA17138

cGvHD
Action Outputs

The main aim and objective of the Action was to establish a European Network to further understand chronic GvHD, through networking and interdisciplinary training.

Frontiers Research Topic- Managing GvHD in the Era of Personalized Medicine

Publications

Profiling Tissue and Biofluid miR-155-5p, miR-155*, and miR-146a-5p Expression in Graft vs. Host Disease

Rachel E. Crossland, Jean Norden, Sakhila Ghimire, Mateja Kralj Juric, Kim F. Pearce, Clare Lendrem, Matthew Collin, Eva Mischak-Weissinger, Ernst Holler, Hildegard T. Greinix and Anne M. Dickinson

Front. Immunol., 15 March 2021
Sec. Alloimmunity and Transplantation
Volume 12 - 202
https://doi.org/10.3389/fimmu.2021.639171

Evaluation of the Cost of Survivorship Care After Allogeneic Hematopoeitic Stem Cell Transplantation-An Analysis of 2 German Transplantation Centers. Frontiers in Public Health.

James M Kilgour, Gorav Wali , Elizabeth Gibbons, Angela Scherwath, Anna Barata Badiella, Andy Peniket , Helene Schoemans , Rubeta N Matin ; cGVHD Eurograft Network

Biol Blood Marrow Transplant. 2020 May;26(5):e113-e127.
doi: 10.1016/j.bbmt.2020.01.022.
Epub 2020 Feb 3.

Neutrophils cause a "NET" increase in skin allograft allogenicity

Brouard S, Mooney N.

Am J Transplant. 2020 Apr;20(4):922-923.Epub 2020 Jan 7
doi: 10.1111/ajt.15746.

A Systematic Review of Patient Reported Outcome Measures in Graft-versus-Host-Disease (GVHD)

Kilgour DJ, Wali DG, Gibbons ME, Scherwath DA, Badiella DAB, Peniket DA, Schoemans DH, Matin DRN.

Biol Blood Marrow Transplant. 2020 May; 26(5):e113-e127.
doi: 10.1016/j.bbmt.2020.01.022.

Chronic gvhd dictionary—eurograft cost action initiative consensus report

Ana Zelić Kerep, Atillio Olivieri, Helene Schoemans, Anita Lawitschka, Jörg Halter, Drazen Pulanic, Anne Dickinson, Hildegard T. Greinix, Steven Z. Pavletic, Kirk R. Schultz, Stephanie J. Lee & Daniel Wolff

Bone Marrow Transplantation volume 58, 68–71 (2023)
doi:10.1038/s41409-022-01837-w

Practice patterns in chronic graft-versus host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network

Vladimir Perovic, Ivan Sabol, Magdalena Grce, Marit Inngjerdingen, Drazen Pulanic, Zinaida Peric, Christophe Peczynski, Emmanuelle Polge, Christian Koenecke, Anne Dickinson, Hildegard Greinix, Grzegorz Basak, Olaf Penack, Angela Scherwath, Anna Barata, Attilio Olivieri, Anita Lawitschka, Patrycja Mensah-Glanowska, Hajnalka Andrikovics, Helene Schoemans & Daniel Wolff

Bone Marrow Transplantation volume 57, 1458–1460 (2022)
doi:10.1038/s41409-022-01733-3

Cell-based therapy in prophylaxis and treatment of chronic graft-versus-host disease

Matteo Doglio; Rachel E. Crossland; Ana C. Alho; Olaf Penack; Anne M. Dickinson; Georg Stary; João F. Lacerda; Günther Eissner; Marit Inngjerdingen

Front. Immunol., 17 November 2022
Sec. Alloimmunity and Transplantation
Volume 13 - 2022 | https://doi.org/10.3389/fimmu.2022.1045168

Post-transplant multimorbidity index and quality of life in patients with chronic graftversus- host disease—results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health

Daniel Wolff, Philipp Y. Herzberg, Anne Herrmann, Steven Z. Pavletic, Pia Heussner, Friederike Mumm, Christina Höfer, Inken Hilgendorf, Philipp G. Hemmati, Ernst Holler, Hildegard Greinix & Sandra A. Mitchell

Bone Marrow Transplantation volume 56, 243–256 (2021)
doi:10.1038/s41409-020-01017-8

Poster Presentations

1. European Society for Blood and Marrow Transplantation 46th annual meeting 2020, Madrid, Spain

Incidence of chronic Graft-versus-Host Disease – results from a prospective multicentre analysis of 2 cohorts.

A. Lelas, R. Langer, M. Rittenschober, L. Desnica, H.Greinix, A. Dickinson, M. Inngjerdingen, A. Lawitschka, R.Vrhovac, D. Pulanic, S. Klein, J.M. Middeke, M. Edinger, D. Wolff

2. European Society for Blood and Marrow Transplantation 46th annual meeting 2020, Madrid, Spain

Practice patterns in chronic GVHD patient management and patient reported outcome measures across the EBMT Allogenic Transplantation Network.

Ivan Sabol, Vladimir Perovic, Magdalena Grce, Marit Inngjerdingen, Drazen Pulanic, Christophe Peczynski, Emmanuelle Polge, Zinaida Peric, Christian Koenecke, Anne Dickinson, Hildegard Greinix, Grzegorz Basak, Olaf Penack, Angela Scherwath, Anna Barata, Attilio Olivieri, Anita Lawitschka, Patrycja Mensah-Glanowska, Hajnalka Andrikovics, Miklos Laszlo Udvardy, Helene Schoemans, Daniel Wolff

Oral Presentations

1. The 34th European Immunogenetics and Histocompatibility Conference annual meeting 2020, Glasgow, UK

Differential expression of miRNAs in chronic Graft-versus-Host Disease.

K. Bogunia-Kubik, P. Lacina1, R. E. Crossland, J. Wielińska, A. Czyż, M. Ussowicz, T. Wróbel, A. Dickinson

Are you interested
in taking part?

If you would like to join the network, have a general query or any suggestion, please connect with us.

Contact us

Get involved

Do you have a question?

If you have any questions or would like to know more about the project, simply connect with us and we’ll be happy to talk to you.